Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells

Liu,Linna; Zhang,Hongmei; Shi,Lei; Zhang,Wenjuan; Yuan,Juanli; Chen,Xiang; Liu,Juanjuan; Zhang,Yan; Wang,Zhipeng

doi:10.3892/or.2014.3388

Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells

Authors:
- Linna Liu
- Hongmei Zhang
- Lei Shi
- Wenjuan Zhang
- Juanli Yuan
- Xiang Chen
- Juanjuan Liu
- Yan Zhang
- Zhipeng Wang
View Affiliations

Affiliations: Department of Pharmaceutics, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China, Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of orthopedics, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
Published online on: August 7, 2014 https://doi.org/10.3892/or.2014.3388
Pages: 1395-1400

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rac1 has been shown to regulate the cell cycle in cancer cells. Yet, the related mechanism remains unclear. Thus, the present study aimed to investigate the mechanism involved in the regulation of G1/S phase transition by Rac1 in cancer cells. Inhibition of Rac1 by inhibitor NSC23766 induced G1/S phase arrest and inhibited the proliferation of A431, SW480 and U2-OS cells. Suppression of GSK3 by shRNA partially rescued G1/S phase arrest and inhibition of proliferation. Incubation of cells with NSC23766 reduced p-AKT and inactivated p-GSK3α and p-GSK3β, increased p-cyclin D1 expression and decreased the level of cyclin D1 protein. Consequently, cyclin D1 targeting transcriptional factor E2F1 expression, which promotes G1 to S phase transition, was also reduced. In contrast, constitutive active Rac1 resulted in increased p-AKT and inactivated p-GSK3α and p-GSK3β, decreased p-cyclin D1 expression and enhanced levels of cyclin D1 and E2F1 expression. Moreover, suppression of GSK3 did not alter p-AKT or Rac1 activity, but decreased p-cyclin D1 and increased total cyclin D1 protein. However, neither Rac1 nor GSK3 inhibition altered cyclin D1 at the RNA level. Moreover, after inhibition of Rac1 or GSK3 following proteasome inhibitor MG132 treatment, cyclin D1 expression at the protein level remained constant, indicating that Rac1 and GSK3 may regulate cyclin D1 turnover through phosphorylation and degradation. Therefore, our findings suggest that inhibition of Rac1 induces cell cycle G1/S arrest in cancer cells by regulation of the GSK3/cyclin D1 pathway.

View Figures

View References

1	Karlsson R, Pedersen ED, Wang Z and Brakebusch C: RhoGTPases function in tumor. Biochim Biophys Acta. 1796:91–98. 2009.PubMed/NCBI
2	Qiu RG, Chen J, McCormick F and Symons M: A role for Rho in Ras transformation. Proc Natl Acad Sci USA. 92:11781–11785. 1995. View Article : Google Scholar : PubMed/NCBI
3	Richard-Parpaillon L, Cosgrove RA, Devine C, Vernon AE and Philpott A: G1/S phase cyclin-dependent kinase overexpression perturbs early development and delays tissue-specific differentiation in Xenopus. Development. 131:2577–2586. 2004. View Article : Google Scholar
4	Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF and Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 1559–1571. 1993. View Article : Google Scholar : PubMed/NCBI
5	Nevins JR: E2F, a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:424–429. 1992. View Article : Google Scholar : PubMed/NCBI
6	Hsieh TC, Yang CJ, Lin CY, Lee YS and Wu JM: Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells. Carcinogenesis. 33:670–677. 2012. View Article : Google Scholar : PubMed/NCBI
7	Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A and Grant S: Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Cancer Res. 73:1340–1351. 2013. View Article : Google Scholar : PubMed/NCBI
8	Moore SF, van den Bosch MT, Hunter RW, Sakamoto K, Poole AW and Hers I: Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin-mediated integrin αIIbβ₃ activation and granule secretion in platelets. J Biol Chem. 288:3918–3928. 2013.
9	Rhee K, Ma T and Thompson EA: The macromolecular state of the transcription factor E2F and glucocorticoid regulation of c-myc transcription. J Biol Chem. 269:17035–17042. 1994.PubMed/NCBI
10	Sahin F and Sladek TL: E2F-1 has dual roles depending on the cell cycle. Int J Biol Sci. 6:116–128. 2010. View Article : Google Scholar : PubMed/NCBI
11	Olson MF, Ashworth A and Hall A: An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science. 269:1270–1272. 1995. View Article : Google Scholar : PubMed/NCBI
12	Joyce D, Bouzahzah B, Fu M, Albanese C, D’Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ and Pestell RG: Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-κB-dependent pathway. J Biol Chem. 274:25245–25249. 1999.PubMed/NCBI
13	Peterson E, Wang Z, Stanley A, Peyrollier K, Quondamatteo F and Brakebusch C: Rac1 in keratinocytes regulates crosstalk to immune cells by Arp2/3 control of STAT1. J Cell Sci. 125:5379–5390. 2012. View Article : Google Scholar : PubMed/NCBI
14	Wang Z, Zhu S, Min Shen, Liu J, Wang M, Li C, Wang Y and Mei Q: STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1. Carcinogenesis. 34:678–688. 2013. View Article : Google Scholar : PubMed/NCBI
15	Wang Z, Pedersen E, Basse A, Lefever T, Karine P, Kapoor S, Mei Q, Karlsson R and Brakebusch C: Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Oncogene. 29:3362–3373. 2010. View Article : Google Scholar : PubMed/NCBI
16	Wang D, Sun SQ, Yu YH, Wu WZ, Yang SL and Tan JM: Suppression of SCIN inhibits human prostate cancer cell proliferation and induces G0/G1 phase arrest. Int J Oncol. 44:161–166. 2014.PubMed/NCBI
17	Chiron D, Martin P, Di Liberto M, Huang X, Ely S, Lannutti BJ, Leonard JP, Mason CE and Chen-Kiang S: Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1. Cell Cycle. 12:1892–1900. 2013.PubMed/NCBI
18	Diehl JA, Cheng M, Roussel MF and Sherr CJ: Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499–3511. 1998.
19	Peng J and Jordan VC: Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells. Int J Oncol. 36:451–458. 2010.PubMed/NCBI
20	Subtil-Rodríguez A, Vázquez-Chávez E, Ceballos-Chávez M, Rodríguez-Paredes M, Martín-Subero JI, Esteller M and Reyes JC: The chromatin remodeller CHD8 is required for E2F-dependent transcription activation of S-phase genes. Nucleic Acids Res. 42:2185–2196. 2014.PubMed/NCBI